Our read is that DHEA supplementation is well supported for specific applications, particularly in women's health and hormonal balance, but carries notable caveats.
Our read is that DHEA supplementation is well supported for specific applications, particularly in women's health and hormonal balance, but carries notable caveats.
For women, DHEA, especially in vaginal forms, shows strong efficacy for conditions like UTIs, dyspareunia, and restoring testosterone levels. However, oral DHEA for men lacks demonstrated utility and may cause estrogen spikes, and for women, it carries a worse risk-to-reward ratio due to side effects like acne.
The cortisol to DHEA ratio is highlighted as a predictor of overall stress, morbidity, and mortality, with DHEA potentially offering metabolic and mental benefits.
For DHEA supplementation, a typical study dose is 25-50mg, though it is advisable to start lower due to potential androgenic side effects, as noted by Rhonda Patrick. Paul Saladino suggests taking 25-50mg of DHEA in the morning to suppress the stress response and normalize blood sugar during stressful activities. Paul Saladino also notes that measuring cortisol and DHEA in the afternoon may be the best time to assess the ratio for optimal health.
Our read is that DHEA supplementation carries a worse risk-to-reward ratio for women due to the common side effect of acne, as noted by Peter Attia. Peter Attia also states that oral DHEA has no discernible utility or effect on testosterone levels in males and may cause a spike in estrogen. Furthermore, Peter Attia indicates that oral DHEA is not recommended for hypoactive sexual desire disorder due to lack of demonstrated efficacy and insufficient safety data.
Our read is that the verdict would change with further robust studies demonstrating efficacy and safety for oral DHEA in men, or for hypoactive sexual desire disorder, or if new data emerged regarding the long-term systemic effects and side effect profiles, particularly for women.
Mechanistic and trial evidence converge on a real, replicable effect.
The intervention improves the primary outcome at standard doses in healthy adults.
Mechanistic and trial evidence converge on a real, replicable effect.
The intervention improves the primary outcome at standard doses in healthy adults.
The intervention improves the primary outcome at standard doses in healthy adults.
Animal-model results don't translate to the human protocol being recommended.
Most of the support comes from short or small studies.
Animal-model results don't translate to the human protocol being recommended.
The headline effect shrinks once you account for trial quality.
Most of the support comes from short or small studies.